Skip to main content
Top
Published in: Supportive Care in Cancer 4/2016

01-04-2016 | Original Article

Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon

Authors: Rei Kawashima, Mio Fujimaki, Yuka Ikenoue, Keiko Danjo, Wasaburo Koizumi, Takafumi Ichikawa

Published in: Supportive Care in Cancer | Issue 4/2016

Login to get access

Abstract

Purpose

The elemental diet (ED) Elental® reportedly reduces adverse reactions to chemotherapy in digestive system cancer patients; however, the mechanism is unclear. Therefore, we verified the protective effect of ED against gastrointestinal disorders induced by the antineoplastic drug 5-fluorouracil (5-FU).

Methods

After 5 days of tail vein injections of 40 mg/kg/day 5-FU in female BALB/c mice, the mice were given oral ED (ED group) or dextrin with the same number of calories (control group). We measured the weight of salivary glands and the PAS-positive area of colonic mucosa and verified the antitumor effect in tumor-bearing mice given 5-FU and ED.

Results

Although body weight decreased after 5-FU treatment, ED group mice weighed more than control group mice. Additionally, although control mice developed diarrhea after 5-FU treatment, the ED group showed only loose stools. The control group saliva volume was approximately one sixth of the vehicle group volume after 5-FU treatment; this was improved to approximately half in the ED group. The area ratio of PAS-positive cells in the colonic mucosa was reduced by 5-FU treatment, with the ratio being higher in the ED group than that in the control group. Similar tumor growth suppression was observed in the 5-FU and ED groups.

Conclusions

ED alleviated adverse reactions to 5-FU without affecting antitumor activity. Protection against 5-FU-induced weight loss was potentially due to both improved nutritional support with combined ingredients and prevention of diarrhea that is associated with reduced colonic goblet cells and decreased saliva production from reduced salivary gland contraction.
Literature
1.
go back to reference Elting LS, Cooksley C, Chambers M, et al. (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539CrossRefPubMed Elting LS, Cooksley C, Chambers M, et al. (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539CrossRefPubMed
2.
go back to reference Slavin RE, Dias MA, Saral R (1978) Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer 42:1747–1759CrossRefPubMed Slavin RE, Dias MA, Saral R (1978) Cytosine arabinoside induced gastrointestinal toxic alterations in sequential chemotherapeutic protocols: a clinical-pathologic study of 33 patients. Cancer 42:1747–1759CrossRefPubMed
3.
go back to reference Lochs H, Dejong C, Hammarqvist F, et al. (2006) ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 25:260–274CrossRefPubMed Lochs H, Dejong C, Hammarqvist F, et al. (2006) ESPEN guidelines on enteral nutrition: gastroenterology. Clin Nutr 25:260–274CrossRefPubMed
4.
go back to reference Homan M, Baldassano RN, Mamula P (2005) Managing complicated Crohn’s disease in children and adolescents. Nat Clin Pract Gastroenterol Hepatol 2:572–579CrossRefPubMed Homan M, Baldassano RN, Mamula P (2005) Managing complicated Crohn’s disease in children and adolescents. Nat Clin Pract Gastroenterol Hepatol 2:572–579CrossRefPubMed
5.
go back to reference Johnson T, Macdonald S, Hill SM, et al. (2006) Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 55:356–361PubMedCentralCrossRefPubMed Johnson T, Macdonald S, Hill SM, et al. (2006) Treatment of active Crohn’s disease in children using partial enteral nutrition with liquid formula: a randomised controlled trial. Gut 55:356–361PubMedCentralCrossRefPubMed
6.
go back to reference Yamamoto T, Nakahigashi M, Umegae S, et al. (2005) Impact of elemental diet on mucosal inflammation in patients with active Crohn’s disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 11:580–588CrossRefPubMed Yamamoto T, Nakahigashi M, Umegae S, et al. (2005) Impact of elemental diet on mucosal inflammation in patients with active Crohn’s disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 11:580–588CrossRefPubMed
7.
go back to reference Kawaguchi T, Mori M, Saito K, et al. (2015) Food antigen-induced immune responses in Crohn’s disease patients and experimental colitis mice. J. Gastroenterol Kawaguchi T, Mori M, Saito K, et al. (2015) Food antigen-induced immune responses in Crohn’s disease patients and experimental colitis mice. J. Gastroenterol
8.
go back to reference Kajiura T, Takeda T, Sakata S, et al. (2009) Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci 54:1892–1900CrossRefPubMed Kajiura T, Takeda T, Sakata S, et al. (2009) Change of intestinal microbiota with elemental diet and its impact on therapeutic effects in a murine model of chronic colitis. Dig Dis Sci 54:1892–1900CrossRefPubMed
9.
go back to reference Andou A, Hisamatsu T, Okamoto S, et al. (2009) Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136:564–774 e2CrossRefPubMed Andou A, Hisamatsu T, Okamoto S, et al. (2009) Dietary histidine ameliorates murine colitis by inhibition of proinflammatory cytokine production from macrophages. Gastroenterology 136:564–774 e2CrossRefPubMed
10.
go back to reference Ogata Y, Takeuchi M, Ishibashi N, et al. (2012) Efficacy of Elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients. Gan To Kagaku Ryoho. 39:583–587PubMed Ogata Y, Takeuchi M, Ishibashi N, et al. (2012) Efficacy of Elental on prevention for chemotherapy-induced oral mucositis in colorectal cancer patients. Gan To Kagaku Ryoho. 39:583–587PubMed
11.
go back to reference Fukui T, Itoh Y, Orihara M, et al. (2011) Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer. Gan To Kagaku Ryoho 38:2597–2601PubMed Fukui T, Itoh Y, Orihara M, et al. (2011) Elental prevented and reduced oral mucositis during chemotherapy in patients esophageal cancer. Gan To Kagaku Ryoho 38:2597–2601PubMed
12.
go back to reference Azuumi Y, Ohara S, Ishihara K, et al. (1980) Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. 21:533–536. Azuumi Y, Ohara S, Ishihara K, et al. (1980) Correlation of quantitative changes of gastric mucosal glycoproteins with aspirin-induced gastric damage in rats. 21:533–536.
13.
go back to reference Ikezawa T, Ichikawa T, Adachi K, et al. (2005) Analysis of mucin composition in gastric juices of chronic rheumatic patients with upper gastrointestinal damage. Biomed Res 26:147–151CrossRefPubMed Ikezawa T, Ichikawa T, Adachi K, et al. (2005) Analysis of mucin composition in gastric juices of chronic rheumatic patients with upper gastrointestinal damage. Biomed Res 26:147–151CrossRefPubMed
14.
go back to reference Kojima Y, Ishihara K, Ohara S, et al. (1992) Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scand J Gastroenterol 27:764–768CrossRefPubMed Kojima Y, Ishihara K, Ohara S, et al. (1992) Effects of the M1 muscarinic receptor antagonist pirenzepine on gastric mucus glycoprotein in rats with or without ethanol-induced gastric damage. Scand J Gastroenterol 27:764–768CrossRefPubMed
15.
go back to reference Ikezawa T, Goso Y, Ichikawa T, et al. (2002) Immunohistochemical localization in rat gastrointestinal tract of a sialomucin species recognized by HCM31, a new anti-mucin monoclonal antibody. Biochem Res. 23:63–68 Ikezawa T, Goso Y, Ichikawa T, et al. (2002) Immunohistochemical localization in rat gastrointestinal tract of a sialomucin species recognized by HCM31, a new anti-mucin monoclonal antibody. Biochem Res. 23:63–68
16.
go back to reference Ishihara K, Kurihara M, Goso Y, et al. (1996) Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconj J 13:857–864CrossRefPubMed Ishihara K, Kurihara M, Goso Y, et al. (1996) Establishment of monoclonal antibodies against carbohydrate moiety of gastric mucins distributed in the different sites and layers of rat gastric mucosa. Glycoconj J 13:857–864CrossRefPubMed
17.
go back to reference Tsubokawa D, Goso Y, Sawaguchi A, et al. (2007) A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin. FEBS J. 274:1833–1848CrossRefPubMed Tsubokawa D, Goso Y, Sawaguchi A, et al. (2007) A monoclonal antibody, PGM34, against 6-sulfated blood-group H type 2 antigen, on the carbohydrate moiety of mucin. FEBS J. 274:1833–1848CrossRefPubMed
18.
go back to reference Saegusa Y, Ichikawa T, Iwai T, et al. (2008) Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43:531–537PubMedCentralCrossRefPubMed Saegusa Y, Ichikawa T, Iwai T, et al. (2008) Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43:531–537PubMedCentralCrossRefPubMed
19.
go back to reference Yamamoto H, Ishihara K, Takeda Y, et al. (2013) Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats. Biomed Res Int. doi:10.1155/2013/276186 Yamamoto H, Ishihara K, Takeda Y, et al. (2013) Changes in the mucus barrier during cisplatin-induced intestinal mucositis in rats. Biomed Res Int. doi:10.​1155/​2013/​276186
20.
go back to reference Imamura TK, Yoshino Y, Yamachika S, et al. (2012) Inhibition of pilocarpine-induced saliva secretion by adrenergic agonists in ICR mice. Clin Exp Pharmacol Physiol. 39:1038–1043CrossRefPubMed Imamura TK, Yoshino Y, Yamachika S, et al. (2012) Inhibition of pilocarpine-induced saliva secretion by adrenergic agonists in ICR mice. Clin Exp Pharmacol Physiol. 39:1038–1043CrossRefPubMed
21.
go back to reference Saegusa Y, Ichikawa T, Iwai T, et al. (2008) Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43:59–65CrossRefPubMed Saegusa Y, Ichikawa T, Iwai T, et al. (2008) Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis. Scand J Gastroenterol 43:59–65CrossRefPubMed
22.
go back to reference Jensen SB, Pedersen AM, Reibel J, et al. (2003) Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11:207–225PubMed Jensen SB, Pedersen AM, Reibel J, et al. (2003) Xerostomia and hypofunction of the salivary glands in cancer therapy. Support Care Cancer 11:207–225PubMed
23.
go back to reference McCarthy GM, Awde JD, Ghandi H, et al. (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490CrossRefPubMed McCarthy GM, Awde JD, Ghandi H, et al. (1998) Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol 34:484–490CrossRefPubMed
24.
go back to reference Harrison T, Bigler L, Tucci M, et al. (1998) Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dentist 18:109–112CrossRefPubMed Harrison T, Bigler L, Tucci M, et al. (1998) Salivary sIgA concentrations and stimulated whole saliva flow rates among women undergoing chemotherapy for breast cancer: an exploratory study. Spec Care Dentist 18:109–112CrossRefPubMed
25.
go back to reference Dumbrigue HB, Sandow PL, Nguyen KH, et al. (2000) Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 89:710–716CrossRefPubMed Dumbrigue HB, Sandow PL, Nguyen KH, et al. (2000) Salivary epidermal growth factor levels decrease in patients receiving radiation therapy to the head and neck. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 89:710–716CrossRefPubMed
26.
go back to reference Iwai T, Ichikawa T, Goso Y, et al. (2009) Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies. J Gastroenterol 44:277–284CrossRefPubMed Iwai T, Ichikawa T, Goso Y, et al. (2009) Effects of indomethacin on the rat small intestinal mucosa: immunohistochemical and biochemical studies using anti-mucin monoclonal antibodies. J Gastroenterol 44:277–284CrossRefPubMed
Metadata
Title
Influence of an elemental diet on 5-fluorouracil-induced morphological changes in the mouse salivary gland and colon
Authors
Rei Kawashima
Mio Fujimaki
Yuka Ikenoue
Keiko Danjo
Wasaburo Koizumi
Takafumi Ichikawa
Publication date
01-04-2016
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 4/2016
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-015-2947-7

Other articles of this Issue 4/2016

Supportive Care in Cancer 4/2016 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine